Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania

European Journal of Cancer

Volumn 63, Issue , 2016, Pages 110-117

  Breugom, A J ^a   Bastiaannet, E ^a   Boelens, P G ^a   Iversen, L H ^b   Martling, A ^c   Johansson, R ^d   Evans, T ^e   Lawton, S ^e   O'Brien, K M ^f   Van Eycken, E ^g   Janciauskiene, R ^h   Liefers, G J ^a   Cervantes, A ⁱ   Lemmens, V E P P ^j,k   Van De Velde, C J H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^g Belgian Cancer Registry   (Belgium)

^h LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

ⁱ UNIVERSITY OF VALENCIA   (Spain)

^j Netherlands Comprehensive Cancer Organisation ^*  (Netherlands)

^k ERASMUS MEDICAL CENTER   (Netherlands)

more..

Author keywords

Adjuvant chemotherapy; Colon cancer; International comparison; Population based; Stage II; Surgery

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BELGIUM; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; COMPARATIVE STUDY; DENMARK; ENGLAND; FEMALE; FOLLOW UP; HUMAN; IRELAND; LITHUANIA; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; SWEDEN; COLONIC NEOPLASMS; EUROPE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; STATISTICAL MODEL; SURVIVAL ANALYSIS;

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; EUROPE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 84974632949     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2016.04.017     Document Type: Article

References (30)

1. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J.W. Coebergh, H. Comber, and et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur J Cancer 49 6 2013 1374 1403
2. Netherlands Cancer Registry. http://cijfersoverkanker.nl/selecties/Dataset-1/img559e9911e8351 [accessed November 2015].
3. C.G. Moertel, T.R. Fleming, J.S. Macdonald, D.G. Haller, J.A. Laurie, P.J. Goodman, and et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med 322 6 1990 352 358
4. D.G. Haller, P.J. Catalano, J.S. Macdonald, M.A. O'Rourke, M.S. Frontiera, D.V. Jackson, and et al. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089 J Clin Oncol 23 34 2005 8671 8678
5. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators Lancet 345 8955 1995 939 944
6. M.J. O'Connell, J.A. Mailliard, M.J. Kahn, J.S. Macdonald, D.G. Haller, R.J. Mayer, and et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer J Clin Oncol 15 1 1997 246 250
7. C. Twelves, A. Wong, M.P. Nowacki, M. Abt, H. Burris 3rd, A. Carrato, and et al. Capecitabine as adjuvant treatment for stage III colon cancer N Engl J Med 352 26 2005 2696 2704
8. G. Yothers, M.J. O'Connell, C.J. Allegra, J.P. Kuebler, L.H. Colangelo, N.J. Petrelli, and et al. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses J Clin Oncol 29 28 2011 3768 3774
9. T. André, C. Boni, M. Navarro, J. Tabernero, T. Hickish, C. Topham, and et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial J Clin Oncol 27 19 2009 3109 3116
10. H.J. Schmoll, C. Twelves, W. Sun, M.J. O'Connell, T. Cartwright, E. McKenna, and et al. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials Lancet Oncol 15 13 2014 1481 1492
11. H.J. Schmoll, E. Van Cutsem, A. Stein, V. Valentini, B. Glimelius, K. Haustermans, and et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making Ann Oncol 23 10 2012 2479 2516
12. R. Labianca, B. Nordlinger, G.D. Beretta, S. Mosconi, M. Mandala, A. Cervantes, and et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 24 Suppl. 6 2013 vi64 vi72
13. A. Figueredo, M.E. Coombes, and S. Mukherjee Adjuvant therapy for completely resected stage II colon cancer Cochrane Database Syst Rev 3 2008 CD005390
14. M.A. Elferink, K.P. de Jong, J.M. Klaase, E.J. Siemerink, and J.H. de Wilt Metachronous metastases from colorectal cancer: a population-based study in North-East Netherlands Int J Colorectal Dis 30 2 2015 205 212
15. B. Holleczek, S. Rossi, A. Domenic, K. Innos, P. Minicozzi, S. Francisci, and et al. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 - Results from the EUROCARE-5 study Eur J Cancer 51 15 2015 2158 2168
16. D. Ait Ouakrim, C. Pizot, M. Boniol, M. Malvezzi, M. Boniol, E. Negri, and et al. Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database BMJ 351 2015 h4970
17. P. Sullivan, and D. Goldmann The promise of comparative effectiveness research JAMA 305 4 2011 400 401
18. M. Schemper, and T.L. Smith A note on quantifying follow-up in studies of failure time Control Clin Trials 17 4 1996 343 346
19. T. Hakulinen, K. Seppa, and P.C. Lambert Choosing the relative survival method for cancer survival estimation Eur J Cancer 47 14 2011 2202 2210
20. B.G. Taal, H. Van Tinteren, F.A. Zoetmulder NACCP Group Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III Br J Cancer 85 10 2001 1437 1443
21. L.N. van Steenbergen, M.A. Elferink, P. Krijnen, V.E. Lemmens, S. Siesling, H.J. Rutten, and et al. Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006 Ann Oncol 21 11 2010 2206 2212
22. W. Hohenberger, K. Weber, K. Matzel, T. Papadopoulos, and S. Merkel Standardized surgery for colonic cancer: complete mesocolic excision and central ligation-technical notes and outcome Colorectal Dis 11 4 2009 354 364
23. C.A. Bertelsen, A.U. Neuenschwander, J.E. Jansen, M. Wilhelmsen, A. Kirkegaard-Klitbo, J.R. Tenma, and et al. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study Lancet Oncol 16 2 2015 161 168
24. H. Brenner, M. Kloor, and C.P. Pox Colorectal cancer Lancet 383 9927 2014 1490 1502
25. E.J. Van Cutsem, and V.V. Kataja ESMO minimum clinical recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer Ann Oncol 16 Suppl. 1 2005 i16 i17
26. S.R. Verhoeff, F.N. van Erning, V.E. Lemmens, J.H. de Wilt, and J.F. Pruijt Adjuvant chemotherapy is not associated with improved survival for all high risk factors in stage II colon cancer Int J Cancer 139 1 2016 187 193
27. R. Bernhoff, A. Martling, A. Sjövall, F. Granath, W. Hohenberger, and T. Holm Improved survival after an educational project on colon cancer management in the county of Stockholm - a population based cohort study Eur J Surg Oncol 41 11 2015 1479 1484
28. G. Gatta, R. Capocaccia, M. Sant, C.M. Bell, J.W. Coebergh, R.A. Damhuis, and et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study Gut 47 4 2000 533 538
29. The Lancet Oncology Is UK cancer care broken? Lancet Oncol 16 13 2015 1273
30. H.H. Storm, G. Engholm, R. Pritzkuleit, A.M. Kejs, A. Katalinic, J. Dunst, and et al. Less pitfalls and variation in population based cancer survival comparisons within the European Union: lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project Eur J Cancer 51 9 2015 1188 1198